Because they affect the brain, the drugs cause a wide range of sensations and experiences. The drugs influence brain function by acting on chemicals called neurotransmitters, which can have profound effects on mood, learning, perceptions, and movement. And Sweetsur, P. (2007), ‘The prevalence of use, dependency and harms of legal ‘party pills’ containing benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP) in New Zealand’, Journal of Substance Use, Volume 12, No 3, pp. 213–224. (2007), ‘Legal piperazine-containing party pills – a new trend in substance misuse’, Drug and Alcohol Review, Volume 26, No 3, pp. 335–343. (2003), ‘Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry’, Journal of Mass Spectrometry, Volume 38, No 6, pp. 659–76. The piperazine derivatives are not chemically similar to any of the more common substances of misuse, but have a more distant connection with phencyclidine and with 1-phenylethylamine and its derivatives.
Drugs And Inhalants
High doses of BZP when bound to the 5-HT2 receptor, produce an effect approximately 10 times weaker than that of MDMA 24,25,26. In addition, it increases the level of DA and NA, which leads to effects similar to those of amphetamine 27. The simultaneous use of BZP with TFMPP or mCPP mimics the ecstasy profile, i.e., the levels of dopamine and serotonin increase 28. The stimulant effects are a result of the action of BZP, and hallucinations have been observed after TFMPP 29. Phenylpiperazine derivatives are sold together with BZP for enhanced effects on the body.
Classification Of Psychedelics And Psychoactive Drugs Based On Brain-wide Imaging Of Cellular C-Fos Expression
Health care providers are seeing an increased number of patients under the influence of several new psychoactive drug classes. Synthetic cannabinoids, cathinones, and piperazines are sought by users for their psychoactive effects, perceived safety profile, minimal legal regulations, and lack of detection on routine urine drug screening. However, these drugs are beginning to be recognized by the medical community for their toxic effects. The neuropsychiatric and cardiovascular toxicities are among the most common reasons for emergency medical treatment, which in some cases, can be severe and even life-threatening.
Is It Dangerous To Mix With Other Drugs?
According to animal studies, its effects are less potent than amphetamine, methamphetamine and MDMA 10. TFMPP, used in conjunction with BZP, has been reported to produce some of the effects of MDMA, but with a lower potency 11, while mCPP has been indicated to produce similar stimulant and hallucinogenic effects as MDMA 12. The presented methods enable the detection of piperazine designer drugs in a different concentration range and additionally in a short time of analysis. Rapid analytical confirmation of the cause of poisoning is essential in medical interventions that save human health and life.
Legal Status TFMPP
The proposed methods may be useful techniques in situations requiring analytical confirmation of piperazine designer drug poisoning and may be helpful in comprehensive toxicological diagnostics. The available literature and data indicate an increasing number and chemical diversity of new psychoactive substances (NPS), also known as designer drugs 1,2,3. Products of this type are advertised as a modern alternative to illegal drugs, the possession and sale of which is prohibited by law 4,5. The growing popularity of NPS, the possibility of online purchase and the large number of people experimenting with these compounds is a visible problem in Europe and around the world 6,7,8.
Methamphetamine, for example, displays nearly 30-fold greater potency as a releaser of 3HDA vs 3H5-HT in synaptosomes (Rothman et al, 2001), yet low i.v. Doses of methamphetamine evoke comparable increases in dialysate DA and 5-HT in rat nucleus accumbens (Baumann et al, 2002). While we have no simple explanation for such discrepancies, the data serve to illustrate that estimates of drug potency and selectivity based on in vitro findings alone may not necessarily predict in vivo drug actions.
Ecstasy Metabolites And Monoamine Neurotransmitters Upshift The Na+/K+ ATPase Activity In Mouse Brain Synaptosomes
This study aimed to explore the potential for drug-drug interactions involving benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP). This was achieved by determining the effects of BZP and TFMPP on the metabolism of drugs commonly found in the clinical setting by using pooled human liver microsomes. Incubations consisted of a probe substrate (drug of interest), a potential inhibitor (BZP or TFMPP), a suitable enzyme co-factor (NADPH), and pooled human liver microsomes. Loss of substrate was determined by analysing pre- and post-incubation concentrations in the samples by using HPLC/UV analysis. Both TFMPP and BZP were found to inhibit the metabolism of dextromethorphan, caffeine, and ethinyloestradiol.
Effects Of Piperazines
Recreational use of the drug grew over the 1990’s in a number of places including New Zealand and California 1. Join Europe’s leading medical society and discover the many advantages of membership, including free article publication. TFMPP is a synthetic piperazine often combined with BZP in Legalhighs such as Party Pills in New Zealand. On March 18, 2004, the DEA officially classified BZP as a Schedule I drug, so its use in the United States is now regulated by federal law. Any person convicted of possessing and/or selling a Schedule I drug can face a lengthy prison term and hundreds of thousands of dollars in fines.
Piperazine derivatives are usually found in illicit dosage forms as either tablets or capsules, but loose powders also occur. The tablets often carry logos similar to those seen on ‘ecstasy’ tablets. There are no licensed medicinal products in the EU containing BZP or any of the other substances considered here. In the presented studies, analyses were performed using the buffer concentrations of 10 mM, 20 mM and 100 mM. Using a concentration of 10 mM, the obtained results were not satisfactory. On the other hand, using 100 mM, individual compounds were determined, however, it was not possible to separate the mixture of benzyl and phenylpiperazine from one sample.
Department of Justice, “BZP is about 10 to 20 times less potent than amphetamine.” However, just one or two BZP tablets can have extreme negative effects on the people who take them. At doses of 20 milligrams to 100 milligrams, BZP and TFMPP reportedly produce a range of mental experiences lasting six to eight hours. Amphetamine-like effects include euphoria, alertness, a reduced need for both food and sleep, a heightened sense of touch and other pleasurable sensations, and a sense of emotional closeness with others. At higher doses, though, users have reported stomach pain, vomiting, and feelings of extreme anxiety and paranoia.
European Society Of Medicine
- 1-benzylpiperazine (commonly known as BZP), 1-(3-trifluoromethylphenyl)piperazine (commonly known as TFMPP) were listed as Class A controlled drugs in the First Schedule of the Misuse of Drugs Act on 15 November 2010.
- Rapid analytical confirmation of the cause of poisoning is essential in medical interventions that save human health and life.
- Following oral administration of mCPP to healthy human male volunteers, the elimination half-life ranges from 2.6 to 6.1 hours with a wide variation in peak blood levels and bioavailability.
- People who use BZP or TFMPP usually lose interest in food and may stop eating altogether.
Inhibitors of this metabolic pathway can simultaneously potentiate the effects of piperazines leading to dangerous health effects 79. For example, the inhibitor of CYP2D6, thioridazine may increase the plasma concentration of mCPP 9,26. The diagnostic process in clinical toxicology is based on the recognition or the definitive ruling out of acute or chronic poisoning 79. Confirmation of the identity of compounds causing the poisoning is essential in saving lives. The reproducibility of the method was assessed by using control samples at three empirically determined concentration levels of piperazine designer drugs in the linear range of the calibration curve. The reproducibility of peak areas of the piperazine derivatives and the retention times were assessed within the day and between different days.
It is known that TFMPP decreases spontaneous activity in rats exposed to a novel environment (Lucki et al, 1989), and such hypomotility is mediated via activation of 5-HT2C receptors. It is feasible that TFMPP did not decrease motor activity in our experiments because rats were already habituated to housing conditions with an overnight acclimation period. Administration of BZP stimulated a parallel rise in extracellular DA and 5-HT in vivo, but effects on DA were always predominant (see Figure 6).
